Literature DB >> 7410285

Pharmacokinetic study of a sulfametopyrazine/trimethoprim combination (Kelfiprim) in human volunteers.

D S Reeves, M J Bywater, D W Bullock, H A Holt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7410285     DOI: 10.1093/jac/6.5.647

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  4 in total

Review 1.  Clinical pharmacokinetics of enzyme inhibitors in antimicrobial chemotherapy.

Authors:  I D Watson; M J Stewart; D J Platt
Journal:  Clin Pharmacokinet       Date:  1988-09       Impact factor: 6.447

2.  Kelfiprim, a new sulpha-trimethoprim combination, versus cotrimoxazole, in the treatment of urinary tract infections: a multicentre, double-blind trial.

Authors:  E Pisani; M Pavone-Macaluso; F Rocco; F Piaia; F Pirozzi; U Rotolo; M Lamartina; D Melloni; P Larcker
Journal:  Urol Res       Date:  1982-02

3.  Serum and saliva levels of a trimethoprim-sulfamethopyrazine combination in man.

Authors:  A Sardi; M P Vettaro; R Alesina; S Grasso; G Meinardi; I de Carneri; V Tamassia
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

4.  Pharmacokinetic study of the new sulfamethopyrazine-trimethoprim combination (kelfiprim) in renal insufficiency.

Authors:  A Cantaluppi; G Graziani; C Ponticelli; S Grasso; G Meinardi; F Piaia; V Tamassia
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.